文献速递生殖医学

POSEIDON标准患者中与意外低反应或次优反应相关的临床因素

Clinical factors associated with unexpected poor or suboptimal response in Poseidon criteria patients.
PubMed 文献 · Reprod Biomed Online · 2024-01-30

三中心回顾性队列研究(2015-2017年)纳入7625例首次IVF/ICSI常规卵巢刺激周期,按POSEIDON分类卵巢储备充足者中意外低反应204例(9.3%)、次优反应1998例(90.7%);逻辑回归显示AFC、AMH、促性腺激素总剂量、促性腺激素类型及扳机类型与反应不良显著相关(P≤0.02);ROC曲线得出预测低反应或次优反应的AMH阈值为2.87 ng/ml(AUC 0.740)、AFC为12(AUC 0.826)。

要点

  • POSEIDON标准卵巢储备充足者中意外低反应或次优反应的AMH和AFC阈值高于预期。
  • 预测低反应或次优反应:AMH 2.87 ng/ml(AUC 0.740)、AFC 12(AUC 0.826)。
  • 预测低反应:AMH 2.17 ng/ml(AUC 0.741)、AFC 9(AUC 0.835);预测次优反应:AMH 2.97 ng/ml(AUC 0.722)、AFC 12(AUC 0.801)。

核心结论

  • 预测意外低反应或次优反应的AMH和AFC阈值高于预期,对个体化制定IVF刺激方案和剂量有重要启示。

研究设计与样本

  • 三中心回顾性队列研究(2015-2017年),纳入首次IVF和ICSI周期、采用常规卵巢刺激(FSH≥150 IU/天)且符合POSEIDON分类卵巢储备充足标准(AMH≥1.2 ng/ml;AFC≥5)的患者,共7625例。

主要发现

  • 共7625例符合纳入标准:低反应204例(9.3%),次优反应1998例(90.7%)。
  • 逻辑回归识别出低反应或次优反应的显著临床预测因素,包括AFC、AMH、促性腺激素总剂量、促性腺激素类型和扳机类型(P≤0.02)。
  • ROC曲线显示,预测低反应或次优反应的AMH阈值为2.87 ng/ml(AUC 0.740)、AFC为12(AUC 0.826)。
  • 预测低反应的AMH阈值为2.17 ng/ml(AUC 0.741)、AFC为9(AUC 0.835);预测次优反应的AMH阈值为2.97 ng/ml(AUC 0.722)、AFC为12(AUC 0.801)。

关键数值与推荐

  • 卵巢反应分类:低反应为获卵数<4个,次优反应为4-9个,正常反应为≥9个。
  • POSEIDON分类卵巢储备充足标准:AMH≥1.2 ng/ml且AFC≥5。
  • 常规卵巢刺激定义:FSH≥150 IU/天。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What clinical factors are associated with 'unexpected' poor or suboptimal responses to IVF ovarian stimulation per POSEIDON's criteria, and which AMH and AFC threshold values distinguish this population? DESIGN: Tri-centre retrospective cohort study (2015-2017) involving first-time IVF and ICSI cycles with conventional ovarian stimulation (≥150 IU/day of FSH). Eligibility criteria included sufficient ovarian reserve markers according to POSEIDON's classification (AMH ≥1.2 ng/ml; AFC ≥5). Ovarian response categories were poor (<4 oocytes), suboptimal (4-9 oocytes) and normal (≥9 oocytes). Primary outcomes included clinical factors associated with an unexpected poor or suboptimal response to conventional ovarian stimulation using logistic regression analyses, and the threshold values of AMH and AFC predicting increased risk of such responses using ROC curves. RESULTS: A total of 7625 patients met the inclusion criteria: 204 (9.3%) were poor and 1998 (90.7%) were suboptimal responders. Logistic regression identified significant clinical predictors for a poor or suboptimal response, including AFC, AMH, total gonadotrophin dose, gonadotrophin type and trigger type (P ≤ 0.02). The ROC curves indicated that AMH 2.87 ng/ml (AUC 0.740) and AFC 12 (AUC 0.826) were the threshold values predicting a poor or suboptimal response; AMH 2.17 ng/ml (AUC 0.741) and AFC 9 (AUC 0.835) predicted a poor response; and AMH 2.97 ng/ml (AUC 0.722) and AFC 12 (AUC 0.801) predicted a suboptimal response. CONCLUSIONS: The threshold values of AMH and AFC predicting 'unexpected' poor or suboptimal response were higher than expected. These findings have critical implications for tailoring IVF stimulation regimens and dosages.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hochberg A, Dahan MH, Yarali H, et al. Clinical factors associated with unexpected poor or suboptimal response in Poseidon criteria patients. Reprod Biomed Online. 2024. PMID: 38657290. doi:10.1016/j.rbmo.2024.103852

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。